Steven J. Quimby - Concepedia

Author

Steven J. Quimby

Eli Lilly (United States)

Also Known As

Steven J. Quimby, Steven Quimby

Publications

478

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)

About

Steven J. Quimby is an author at Eli Lilly (United States) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	334
2	Biochemistry	4	4	147
3	Natural Sciences	2	2	53
4	Health Sciences	1	1	25
5	Anesthesia	1	1	25

Steven J. Quimby

Publications

424

Citations

H-Index

Page 1

	Year	Citations
LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders Linda M. Rorick‐Kehn, Jeffrey M. Witkin, Michael A. Statnick, Neuropharmacology Psychoactive DrugPsychiatryFunctional SelectivityMedicineAnimal Models	2013	148
Synthesis and Evaluation of<sup>11</sup>C-LY2795050 as a κ-Opioid Receptor Antagonist Radiotracer for PET Imaging Ming‐Qiang Zheng, Nabeel Nabulsi, Su Kim, Journal of Nuclear Medicine	2013	90
Discovery of Aminobenzyloxyarylamides as κ Opioid Receptor Selective Antagonists: Application to Preclinical Development of a κ Opioid Receptor Antagonist Receptor Occupancy Tracer Charles H. Mitch, Steven J. Quimby, Concepción Pedregal, Journal of Medicinal Chemistry Molecular PharmacologyReceptor Occupancy TracersPreclinical DevelopmentBiochemistryTracer Evaluation	2011	82
Discovery and characterization of [(cyclopentyl)ethyl]benzoic acid inhibitors of microsomal prostaglandin E synthase-1 Katherine M. Partridge, Stephen Antonysamy, Shobha Bhattachar, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryChemoprevention StrategyBiochemistryNatural SciencesMedicine	2016	27
Characterization of 3,3-dimethyl substituted N-aryl piperidines as potent microsomal prostaglandin E synthase-1 inhibitors Steven L. Kuklish, Stephen Antonysamy, Shobha Bhattachar, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ScienceBiochemistryMedicineNatural Sciences	2016	26
Muscarinic Analgesics with Potent and Selective Effects on the Gastrointestinal Tract: Potential Application for the Treatment of Irritable Bowel Syndrome Charles H. Mitch, Thomas J. Brown, Frank P. Bymaster, Journal of Medicinal Chemistry Gastrointestinal PharmacologyPain MedicineGastroenterologyMolecular PainPharmacotherapy	1997	25
SAR and biological evaluation of novel trans-3,4-dimethyl-4-arylpiperidine derivatives as opioid antagonists Mark J. Benvenga, Paul J. Emmerson, Ryan Favors, Bioorganic & Medicinal Chemistry Letters Opioid AntagonistsPharmacologyPharmacological AgentPharmacotherapyBiological Evaluation	2005	14
Structure activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 2 Kumiko Takeuchi, William G. Holloway, Charles H. Mitch, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyCarboxamido-biaryl EthersBiochemistryMedicineMechanism Of Action	2007	12

Page 1